Insmed competitors

Insmed's competitors include Mast Therapeutics, Clinigen Group, Amicus Therapeutics and Remedi SeniorCare
Add company...
Insmed
We are a publicly traded (NASDAQ: INSM) biopharmaceutical company dedicated to improving the lives of patients battling serious lung
Mast Therapeutics
A San Diego-based biopharmaceutical company.
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Remedi SeniorCare
Remedi SeniorCare provides pharmacy services by offering automatic therapeutic interchange education and consulting and transition services.
Founding Date
Founding Date
N/A
Founding Date
1995
Founding Date
2010
Founding Date
2002
Founding Date
1954
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Bridgewater, US HQ
Paris, FR
Frankfurt Am Main, DE
Dublin, IE
Amsterdam, NL
Utrecht, NL
London, GB
Locations
San Diego, US HQ
Locations
Burton upon Trent, GB HQ
Locations
Cranbury Township, US HQ
Puteaux, FR
Munich, DE
Amsterdam, NL
Denham, GB
Locations
Towson, US HQ
Rosedale, US
Ashland, US
Troy, US
Euclid, US
Oklahoma City, US
Plano, US
see more
Employees
Employees
161
Employees
14133% increase
Employees
465200% increase
Employees
263
Employees
4282% increase
Valuation ($)
Valuation ($)
2 b
Valuation ($)
371.8 m
Valuation ($)
1.8 b
Valuation ($)
3 b
Valuation ($)
N/A
Facebook likes
Facebook likes
N/A
Facebook likes
310
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
145
Twitter followers
Twitter followers
N/A
Twitter followers
873
Twitter followers
1.2 k
Twitter followers
793
Twitter followers
76

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£302.3m (FY, 2017)
Revenue (est.)
$36.9m (FY, 2017)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
£179.6m (FY, 2017)
Cost of goods
$6.2m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
£122.7m (FY, 2017)
Gross profit
$30.7m (FY, 2017)
Gross profit
N/A
Net income
Net income
($176.3m) (FY, 2016)
Net income
($29.8m) (FY, 2017)
Net income
£3.8m (FY, 2017)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 100m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 88m
Total funding raised
$ 300m
For sources of this data, please see the company profileDownload Excel

View company profiles

Mast Therapeutics
HQ
San Diego, US
Employees
14

A San Diego-based biopharmaceutical company.

View company
Clinigen Group
HQ
Burton upon Trent, GB
Employees
465

A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time

View company
Amicus Therapeutics
HQ
Cranbury Township, US
Employees
263

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company
Remedi SeniorCare
HQ
Towson, US
Employees
428↑ 2% increase

Remedi SeniorCare provides pharmacy services by offering automatic therapeutic interchange education and consulting and transition services.

View company